. IgG, wells coated with isotype-specific IgGs; Media, non-activated cells incubated with media alone; CTSL-Inh., cathepsin L inhibitor; Ab (block), function blocking mAb to CTSL; Ab (non-block), mAb to CTSL that does not block its activity. Data represent the mean values ± SD of mean fluorescence intensity (MFI) and are derived from three independent experiments (n = 3). *, p < 0.05 when comparing intracellular C3a levels of CD3 and CD46-activated cells with and without inhibitor or when comparing extracellular C3a levels between CD3-activated or CD3 and CD46-activated cells with and without inhibitor (paired t-test with Bonferroni correction). (B) Freshly purified human CD4 + T cells were lysed. Cell lysates were separated using polyacrylamide gel electrophoresis (10% gel) and then analysed by Western blotting using a rabbit antibody against human C3d (left panel) or a rabbit antibody raised against human cathepsin L (CTSL). Human purified C3b (pC3b) and C3 (pC3) and recombinant human CTSL Statistical significance was determined using the two-tailed Mann-Whitney test. Figure S4 , related to 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Mice. Previously described C3-deficient mice (Wessels et al., 1995) were provided with matching wild type C57BL/6 animals by Prof. M. Botto (Imperial College, London). Ctsldeficient and transgenic Tg(K14-hCV);Ctsl-deficient mice were generated as previously described (Hagemann et al., 2004) and back crossed onto C57Bl/6 background for at least 8
generations. All animals were cared for in accordance with institutional guidelines.
Antibodies, proteins and inhibitors. Cell-stimulating mAbs were bought from BD Biosciences, San Diego, CA (anti-human CD28, CD28.2; anti-mouse CD3, 145-2C11; antimouse CD28, 37.51), purified from a specific hybridoma (anti-CD3; OKT-3) or generated in- neo-epitope was a gift from Jörg Köhl (University of Lübeck, Germany (Hartmann et al., 1993) ); mouse monoclonal antibody detecting C3a within the C3 -chain was from Abcam (ab36385). C3aR antibodies for microscopy and FACS were from Abcam (ab126250) and BD Biosciences (561178). C3 cleavage-blocking rabbit antibody to human CTSL (ab58991;
this antibody also detects mouse cathepsin L), non-blocking mouse antibody to human CTSL (ab6314) and rabbit polyclonal antibodies to calnexin (ab22595), EEA1 (ab2900), Lamp1 (ab24170), Rab5 (ab13253), and -actin loading control (ab8226) were purchased from Teffs were activated in 48-well culture plates (2.5-3.5 x 10 5 cells/well) coated with mAbs to CD3, CD28 ± CD46 (2.0 g/ml each) and addition of 25 U/ml rhIL-2. Treg suppression assays were carried out as previously described using the CFSE method (Afzali et al., 2013) .
For suppression assays using CD46-def. Tregs, due to small cell numbers, incorporation of tritiated thymidine was used as readout, as described (Afzali et al., 2011) . Mouse CD4 + T cells, isolated from spleens using mCD4 Microbeads (Miltenyi), were activated in 48-well plates coated with antibodies to mouse CD3+CD28 in the presence of rIL-2 (20 ng/ml), mIL-12 (20 ng/ml) and anti-mIL-4 (10 g/ml) for Th1-skewing or in the presence of rIL-2 (20 ng/ml), mIL-4 (20 ng/ml) and anti-mIFN- (10 g/ml) for Th2-skewing for 3 days, then expanded in rIL-2 until day 7. Cytokine production was assessed after CD3 + CD28 restimulation over night or exposure to PMA and ionomycin for 4 hours.
RT-PCR.
Primers used to quantify mRNA transcription shown in Figure 1C : C3, Forward (F)
